Celcuity

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Celcuity 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CELC

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. 

CEO
Brian F. Sullivan
CEOBrian F. Sullivan
Employees
155
Employees155
Headquarters
Minneapolis, Minnesota
HeadquartersMinneapolis, Minnesota
Founded
2012
Founded2012
Employees
155
Employees155

CELC Key Statistics

Market cap
3.53B
Market cap3.53B
Price-Earnings ratio
-16.77
Price-Earnings ratio-16.77
Dividend yield
—
Dividend yield—
Average volume
1.08M
Average volume1.08M
High today
$75.88
High today$75.88
Low today
$70.68
Low today$70.68
Open price
$75.25
Open price$75.25
Volume
1.39M
Volume1.39M
52 Week high
$151.02
52 Week high$151.02
52 Week low
$45.03
52 Week low$45.03

Stock Snapshot

As of today, Celcuity(CELC) shares are valued at $72.10. The company's market cap stands at 3.53B, with a P/E ratio of -16.77.

On 2026-10-04, Celcuity(CELC) stock moved within a range of $70.68 to $75.88. With shares now at $72.10, the stock is trading +2.0% above its intraday low and -5.0% below the session's peak.

Trading volume for Celcuity(CELC) stock has reached 1.39M, versus its average volume of 1.08M.

The stock's 52-week range extends from a low of $45.03 to a high of $151.02.

The stock's 52-week range extends from a low of $45.03 to a high of $151.02.

CELC News

Simply Wall St 1d
How REVTORPYK Launch Will Impact Celcuity Investors - Simply Wall Street

...

How REVTORPYK Launch Will Impact Celcuity Investors - Simply Wall Street
TipRanks 2d
Celcuity adds seasoned director amid oncology commercialization push

Celcuity ( (CELC) ) just unveiled an announcement. On October 1, 2026, Celcuity’s board expanded its size from eight to nine members and appointed veteran life...

TipRanks 2d
Celcuity appoints Gryska to Board of Directors

Celcuity (CELC) announced the appointment of David Gryska to its Board of Directors. Throughout the past 25 years, Gryska has served on the Boards of eight publ...

Analyst ratings

100%

of 12 ratings
Buy
100%
Hold
0%
Sell
0%

More CELC News

The Motley Fool 3d
Why Celcuity Stock Was a Winner on Wednesday

On a generally forgettable Wednesday for the stock market, with many titles dropping in value, Celcuity (CELC +2.77%) stood out by posting a gain. Investors bou...

Why Celcuity Stock Was a Winner on Wednesday
TipRanks 4d
Celcuity announces REVTORPYK is now commercially available in U.S.

Celcuity (CELC) announced that REVTORPYK is now commercially available in the United States for eligible patients with hormone receptor-positive, human epiderma...

People also own

Based on the portfolios of people who own CELC. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.